Related Experiment Video
Updated: Mar 18, 2026
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
Brain Metastasis From Malignant Peripheral Nerve Sheath Tumors
Ross C Puffer1, Christopher S Graffeo1, Grant W Mallory1
1Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota, USA.
Brain metastases from malignant peripheral nerve sheath tumors (MPNSTs) are rare but indicate a poor prognosis. Early diagnosis and treatment of MPNSTs are crucial for improving patient survival outcomes.
Area of Science:
- Neuro-oncology
- Surgical oncology
- Medical oncology
Background:
- Malignant peripheral nerve sheath tumors (MPNSTs) can metastasize.
- Brain metastasis from MPNSTs is an uncommon occurrence.
Observation:
- A case of a 56-year-old man with sciatic nerve MPNST who developed brain metastasis is presented.
- Retrospective review of 179 MPNST patients revealed one case (0.5%) of brain metastasis.
- Literature search identified 21 additional cases of MPNST brain metastasis.
Findings:
- The mean age of patients with MPNST brain metastasis was 37.5 years.
- The mean survival after developing brain metastasis was 9.9 months.
- MPNST brain metastases are associated with a poor prognosis, with survival around 10 months.
Implications:
- Aggressive management and early detection of MPNSTs are critical.
- Effective initial treatment may improve overall survival in MPNST patients.
- Understanding rare metastatic patterns like brain involvement is vital for comprehensive cancer care.
More Related Videos
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
07:10Orthotopic Xenografting of Human Luciferase-Tagged Malignant Peripheral Nerve Sheath Tumor Cells for in vivo Testing of Candidate Therapeutic Agents
Published on: March 7, 2011
